Market Cap

Samsung Biologics Co.,Ltd. Market Capitalization:

₩73.879 Trillion

KRW as of July 1, 2025

US$54.48 Billion

business Samsung Biologics Co.,Ltd. Company Profile

Samsung Biologics Co.,Ltd. Main Stock Listing

KRX: 207940

Market Capitalization History of Samsung Biologics Co.,Ltd.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $309.91 B
Vertex Pharmaceuticals Incorporated $117.36 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $59.14 B
Marinomed Biotech AG $58.56 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $699.59 B
Johnson & Johnson $374.29 B
AbbVie $336.94 B
Novo Nordisk $309.91 B
UnitedHealth Group $279.90 B

Yearly evolution of Samsung Biologics Co.,Ltd. market cap

Date Market Cap YoY Change
Jan. 1, 2025 ₩72.242 T 31.01%
Jan. 1, 2024 ₩55.141 T -1.93%
Jan. 1, 2023 ₩56.227 T 7.44%
Jan. 1, 2022 ₩52.333 T -6.81%
Jan. 1, 2021 ₩56.157 T 63.67%
Jan. 1, 2020 ₩34.310 T 21.43%
Jan. 1, 2019 ₩28.255 T -9.01%
Jan. 1, 2018 ₩31.053 T 172.36%
Jan. 1, 2017 ₩11.401 T

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +327.04%

$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Samsung Biologics Co.,Ltd. Categories

South Korea languages Healthcare languages Biotechnology
South Korea Healthcare South Korea Biotechnology

Stocks & Indices

Samsung Biologics Co.,Ltd. has the following listings and related stock indices.


Stock: KRX: 207940

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.